Search Results - Benoit Godbert
- Showing 1 - 3 results of 3
-
1
-
2
Long-Term Response and Survival in Extensive-Stage SCLC Receiving Atezolizumab Plus Chemotherapy in a Real-World Setting: IFCT-1905 CLINATEZO by Lionel Falchero, MD, Karim Amrane, MD, Benoît Godbert, MD, Bénédicte Leterre, MD, Jeannick Madelaine, MD, Pierre Fournel, MD, PhD, Céline Mascaux, MD, PhD, Judith Raimbourg, MD, Sophie Schneider, MD, Aurélie Swalduz, MD, Rémi Veillon, MD, Alexandra Langlais, MSc, Pascale Missy, PhD, Franck Morin, MSc, Virginie Westeel, MD, PhD, Nicolas Girard, MD, PhD
Published in JTO Clinical and Research Reports (2026-04-01)Get full text
Article -
3
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study by Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Published in Journal for ImmunoTherapy of Cancer (2019-12-01)Get full text
Article
